According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Prostate Cancer Medicine Market

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.

The global Prostate Cancer Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Medicine.

Report Scope

The Prostate Cancer Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Medicine Market Report

Report Metric	Details
Report Name	Prostate Cancer Medicine Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	LHRH Antagonists LHRH Analogs Antiandrogens Pipeline Drugs for Hormonal Therapy
Segment by Application	Age Below 55 Age 55-75 Age Above 75
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Abbott Laboratories, Astellas Pharma Inc., Roche Holding AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Prostate Cancer Medicine Market report?

Ans: The main players in the Prostate Cancer Medicine Market are AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Abbott Laboratories, Astellas Pharma Inc., Roche Holding AG

What are the Application segmentation covered in the Prostate Cancer Medicine Market report?

Ans: The Applications covered in the Prostate Cancer Medicine Market report are Age Below 55, Age 55-75, Age Above 75

What are the Type segmentation covered in the Prostate Cancer Medicine Market report?

Ans: The Types covered in the Prostate Cancer Medicine Market report are LHRH Antagonists, LHRH Analogs, Antiandrogens, Pipeline Drugs for Hormonal Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 LHRH Antagonists

1.2.3 LHRH Analogs

1.2.4 Antiandrogens

1.2.5 Pipeline Drugs for Hormonal Therapy

1.3 Market by Application

1.3.1 Global Prostate Cancer Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Medicine Market Perspective (2019-2030)

2.2 Prostate Cancer Medicine Growth Trends by Region

2.2.1 Global Prostate Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Cancer Medicine Historic Market Size by Region (2019-2024)

2.2.3 Prostate Cancer Medicine Forecasted Market Size by Region (2025-2030)

2.3 Prostate Cancer Medicine Market Dynamics

2.3.1 Prostate Cancer Medicine Industry Trends

2.3.2 Prostate Cancer Medicine Market Drivers

2.3.3 Prostate Cancer Medicine Market Challenges

2.3.4 Prostate Cancer Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Medicine Players by Revenue

3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2019-2024)

3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue

3.4 Global Prostate Cancer Medicine Market Concentration Ratio

3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2023

3.5 Prostate Cancer Medicine Key Players Head office and Area Served

3.6 Key Players Prostate Cancer Medicine Product Solution and Service

3.7 Date of Enter into Prostate Cancer Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Medicine Breakdown Data by Type

4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2019-2024)

4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2025-2030)

5 Prostate Cancer Medicine Breakdown Data by Application

5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2019-2024)

5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Cancer Medicine Market Size (2019-2030)

6.2 North America Prostate Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Prostate Cancer Medicine Market Size by Country (2019-2024)

6.4 North America Prostate Cancer Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Medicine Market Size (2019-2030)

7.2 Europe Prostate Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Prostate Cancer Medicine Market Size by Country (2019-2024)

7.4 Europe Prostate Cancer Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2019-2030)

8.2 Asia-Pacific Prostate Cancer Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Prostate Cancer Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Medicine Market Size (2019-2030)

9.2 Latin America Prostate Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Prostate Cancer Medicine Market Size by Country (2019-2024)

9.4 Latin America Prostate Cancer Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2019-2030)

10.2 Middle East & Africa Prostate Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca plc

11.1.1 AstraZeneca plc Company Detail

11.1.2 AstraZeneca plc Business Overview

11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction

11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2019-2024)

11.1.5 AstraZeneca plc Recent Development

11.2 Active Biotech

11.2.1 Active Biotech Company Detail

11.2.2 Active Biotech Business Overview

11.2.3 Active Biotech Prostate Cancer Medicine Introduction

11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2019-2024)

11.2.5 Active Biotech Recent Development

11.3 Bristol Myers-Squibb

11.3.1 Bristol Myers-Squibb Company Detail

11.3.2 Bristol Myers-Squibb Business Overview

11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction

11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2019-2024)

11.3.5 Bristol Myers-Squibb Recent Development

11.4 Teva Pharmaceuticals Industries Ltd.

11.4.1 Teva Pharmaceuticals Industries Ltd. Company Detail

11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview

11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction

11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2019-2024)

11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Detail

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction

11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2019-2024)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer Inc.

11.6.1 Pfizer Inc. Company Detail

11.6.2 Pfizer Inc. Business Overview

11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction

11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2019-2024)

11.6.5 Pfizer Inc. Recent Development

11.7 Bayer AG

11.7.1 Bayer AG Company Detail

11.7.2 Bayer AG Business Overview

11.7.3 Bayer AG Prostate Cancer Medicine Introduction

11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2019-2024)

11.7.5 Bayer AG Recent Development

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Detail

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction

11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2019-2024)

11.8.5 Abbott Laboratories Recent Development

11.9 Astellas Pharma Inc.

11.9.1 Astellas Pharma Inc. Company Detail

11.9.2 Astellas Pharma Inc. Business Overview

11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction

11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2019-2024)

11.9.5 Astellas Pharma Inc. Recent Development

11.10 Roche Holding AG

11.10.1 Roche Holding AG Company Detail

11.10.2 Roche Holding AG Business Overview

11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction

11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2019-2024)

11.10.5 Roche Holding AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Active Biotech

Bristol–Myers Squibb

Teva Pharmaceuticals Industries Ltd

List of Tables

Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of LHRH Antagonists

Table 3. Key Players of LHRH Analogs

Table 4. Key Players of Antiandrogens

Table 5. Key Players of Pipeline Drugs for Hormonal Therapy

Table 6. Global Prostate Cancer Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Prostate Cancer Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Prostate Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Prostate Cancer Medicine Market Share by Region (2019-2024)

Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Prostate Cancer Medicine Market Share by Region (2025-2030)

Table 12. Prostate Cancer Medicine Market Trends

Table 13. Prostate Cancer Medicine Market Drivers

Table 14. Prostate Cancer Medicine Market Challenges

Table 15. Prostate Cancer Medicine Market Restraints

Table 16. Global Prostate Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Prostate Cancer Medicine Market Share by Players (2019-2024)

Table 18. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2023)

Table 19. Ranking of Global Top Prostate Cancer Medicine Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Prostate Cancer Medicine Product Solution and Service

Table 23. Date of Enter into Prostate Cancer Medicine Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2019-2024)

Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2025-2030)

Table 29. Global Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Prostate Cancer Medicine Revenue Market Share by Application (2019-2024)

Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Prostate Cancer Medicine Revenue Market Share by Application (2025-2030)

Table 33. North America Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Prostate Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 48. AstraZeneca plc Company Detail

Table 49. AstraZeneca plc Business Overview

Table 50. AstraZeneca plc Prostate Cancer Medicine Product

Table 51. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 52. AstraZeneca plc Recent Development

Table 53. Active Biotech Company Detail

Table 54. Active Biotech Business Overview

Table 55. Active Biotech Prostate Cancer Medicine Product

Table 56. Active Biotech Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 57. Active Biotech Recent Development

Table 58. Bristol Myers-Squibb Company Detail

Table 59. Bristol Myers-Squibb Business Overview

Table 60. Bristol Myers-Squibb Prostate Cancer Medicine Product

Table 61. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 62. Bristol Myers-Squibb Recent Development

Table 63. Teva Pharmaceuticals Industries Ltd. Company Detail

Table 64. Teva Pharmaceuticals Industries Ltd. Business Overview

Table 65. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product

Table 66. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 67. Teva Pharmaceuticals Industries Ltd. Recent Development

Table 68. Johnson & Johnson Company Detail

Table 69. Johnson & Johnson Business Overview

Table 70. Johnson & Johnson Prostate Cancer Medicine Product

Table 71. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 72. Johnson & Johnson Recent Development

Table 73. Pfizer Inc. Company Detail

Table 74. Pfizer Inc. Business Overview

Table 75. Pfizer Inc. Prostate Cancer Medicine Product

Table 76. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 77. Pfizer Inc. Recent Development

Table 78. Bayer AG Company Detail

Table 79. Bayer AG Business Overview

Table 80. Bayer AG Prostate Cancer Medicine Product

Table 81. Bayer AG Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 82. Bayer AG Recent Development

Table 83. Abbott Laboratories Company Detail

Table 84. Abbott Laboratories Business Overview

Table 85. Abbott Laboratories Prostate Cancer Medicine Product

Table 86. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 87. Abbott Laboratories Recent Development

Table 88. Astellas Pharma Inc. Company Detail

Table 89. Astellas Pharma Inc. Business Overview

Table 90. Astellas Pharma Inc. Prostate Cancer Medicine Product

Table 91. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 92. Astellas Pharma Inc. Recent Development

Table 93. Roche Holding AG Company Detail

Table 94. Roche Holding AG Business Overview

Table 95. Roche Holding AG Prostate Cancer Medicine Product

Table 96. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 97. Roche Holding AG Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Cancer Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Prostate Cancer Medicine Market Share by Type: 2023 VS 2030

Figure 3. LHRH Antagonists Features

Figure 4. LHRH Analogs Features

Figure 5. Antiandrogens Features

Figure 6. Pipeline Drugs for Hormonal Therapy Features

Figure 7. Global Prostate Cancer Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Prostate Cancer Medicine Market Share by Application: 2023 VS 2030

Figure 9. Age Below 55 Case Studies

Figure 10. Age 55-75 Case Studies

Figure 11. Age Above 75 Case Studies

Figure 12. Prostate Cancer Medicine Report Years Considered

Figure 13. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Prostate Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Prostate Cancer Medicine Market Share by Region: 2023 VS 2030

Figure 16. Global Prostate Cancer Medicine Market Share by Players in 2023

Figure 17. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2023

Figure 19. North America Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 21. United States Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 25. Germany Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Prostate Cancer Medicine Market Share by Region (2019-2030)

Figure 33. China Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 41. Mexico Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 45. Turkey Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 48. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 49. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 50. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 51. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 52. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 53. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 54. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 55. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 56. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions